{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:46:23Z","timestamp":1762451183435,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21bk0104089h0003"],"award-info":[{"award-number":["21bk0104089h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21J22613"],"award-info":[{"award-number":["21J22613"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.reth.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T14:07:22Z","timestamp":1663596442000},"page":"389-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficient reprogramming of human fibroblasts using RNA reprogramming with DAPT and iDOT1L under normoxia conditions"],"prefix":"10.1016","volume":"21","author":[{"given":"Kazuki","family":"Morita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8827-8087","authenticated-orcid":false,"given":"Justin","family":"Ichida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Akutsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2022.09.002_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.reth.2022.09.002_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.reth.2022.09.002_bib3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2012.11.039","article-title":"A\u00a0molecular roadmap of reprogramming somatic cells into iPS cells","volume":"151","author":"Polo","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.reth.2022.09.002_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2016.12.016","article-title":"Cooperative binding of transcription factors orchestrates reprogramming","volume":"168","author":"Chronis","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.reth.2022.09.002_bib5","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.celrep.2012.10.014","article-title":"Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency","volume":"2","author":"Hansson","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.reth.2022.09.002_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nature10953","article-title":"Chromatin-modifying enzymes as modulators of reprogramming","volume":"483","author":"Onder","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.reth.2022.09.002_bib7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.stemcr.2021.12.004","article-title":"DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome","volume":"17","author":"Wille","year":"2022","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.reth.2022.09.002_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nchembio.1552","article-title":"Louisiana: Williams, Carter AC, Shi Y, Moura MT, et\u00a0al. Notch inhibition allows oncogene-independent generation of iPS cells","volume":"10","author":"Ichida","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.reth.2022.09.002_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2013.12.005","article-title":"Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics","volume":"14","author":"Chen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2022.09.002_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.755983","article-title":"Cell cluster sorting in automated differentiation of patient-specific induced pluripotent stem cells towards blood cells","volume":"10","author":"Ma","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.reth.2022.09.002_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.reth.2020.08.001","article-title":"The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human na\u00efve-state pluripotency in non-hypoxic conditions","volume":"15","author":"Isono","year":"2020","journal-title":"Regen Ther"},{"key":"10.1016\/j.reth.2022.09.002_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2010.04.015","article-title":"Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming","volume":"7","author":"Samavarchi-Tehrani","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2022.09.002_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41556-018-0195-z","article-title":"Mesenchymal-epithelial transition in development and reprogramming","volume":"21","author":"Pei","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.reth.2022.09.002_bib14","doi-asserted-by":"crossref","first-page":"dev184960","DOI":"10.1242\/dev.184960","article-title":"Mesenchymal-epithelial transition regulates initiation of pluripotency exit before gastrulation","volume":"147","author":"Hamidi","year":"2020","journal-title":"Development"},{"key":"10.1016\/j.reth.2022.09.002_bib15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nature08235","article-title":"Suppression of induced pluripotent stem cell generation by the p53-p21 pathway","volume":"460","author":"Hong","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.reth.2022.09.002_bib16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nature08311","article-title":"Linking the p53 tumour suppressor pathway to somatic cell reprogramming","volume":"460","author":"Kawamura","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.reth.2022.09.002_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/hum.2015.045","article-title":"Efficient reprogramming of human fibroblasts and blood-derived endothelial progenitor cells using nonmodified RNA for reprogramming and immune evasion","volume":"26","author":"Poleganov","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.reth.2022.09.002_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.stem.2014.01.001","article-title":"Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming","volume":"14","author":"Hu","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2022.09.002_bib19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.stem.2014.05.002","article-title":"Molecular control of induced pluripotency","volume":"14","author":"Theunissen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2022.09.002_bib20","article-title":"FOXH1 is regulated by NANOG and LIN28 for early-stage reprogramming","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.reth.2022.09.002_bib21","doi-asserted-by":"crossref","first-page":"dev158360","DOI":"10.1242\/dev.158360","article-title":"p53: emerging roles in stem cells, development and beyond","volume":"145","author":"Jain","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.reth.2022.09.002_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08287","article-title":"A\u00a0p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity","volume":"460","author":"Mari\u00f3n","year":"2009","journal-title":"Nature"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:43:49Z","timestamp":1762451029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320422000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":22,"alternative-id":["S2352320422000888"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2022.09.002","relation":{},"ISSN":["2352-3204"],"issn-type":[{"type":"print","value":"2352-3204"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient reprogramming of human fibroblasts using RNA reprogramming with DAPT and iDOT1L under normoxia conditions","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}